title: Multicenter comparison of rejection reversal: rabbit anti-human lymphocyte serum (ATS) versus horse anti-human lymphocyte globulin (ATGAM).
authors.affiliation: Vanderbilt University Medical Center, Nashville, Tennessee.
authors.forename: K
authors.initials: K
authors.lastname: Johnson
authors.forename: G
authors.initials: G
authors.lastname: Niblack
authors.forename: R
authors.initials: R
authors.lastname: Richie
authors.forename: R
authors.initials: R
authors.lastname: MacDonell
authors.forename: W
authors.initials: W
authors.lastname: Nylander
authors.forename: P
authors.initials: P
authors.lastname: Walker
authors.forename: W
authors.initials: W
authors.lastname: Sterling
authors.forename: G
authors.initials: G
authors.lastname: Ross
authors.forename: A
authors.initials: A
authors.lastname: Humphries
authors.forename: D
authors.initials: D
authors.lastname: Peterson
mesh_terms: D000818:Animals; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000187:drug effects; D006085:Graft Survival / Q000187:drug effects; D006736:Horses; D006801:Humans; D016030:Kidney Transplantation; D015337:Multicenter Studies as Topic; D011817:Rabbits / Q000276:immunology; D011897:Random Allocation
chemical_list: D000961:Antilymphocyte Serum